Shares of biotechnology company Moderna (NASDAQ:MRNA) jumped 3.6% in the afternoon session after the company announced it ...

Shares in drug giant Moderna ($MRNA) were over 5% healthier today after Canada said yes to its Covid vaccine. Health Canada ...

On Monday, Keurig Dr Pepper (KDP) announced that it would spend $18 billion to buy a Dutch coffee giant. KDP shares cratered, ...

Shares of COVID-19 vaccine maker Moderna MRNA rose 13.1% on Jan 2, after analysts at Oppenheimer recently upgraded the stock’s recommendation to Outperform, with a price target of $142 per share.

Even if we look at a slightly longer term, MRNA stock has seen strong gains of 50% from levels of $105 in early January 2021 to around $155 now, vs. an increase of about 40% for the S&P 500 over ...

mRNA vaccine developer Moderna (MRNA) is sinking 9% after Goldman Sachs downgraded the shares to Neutral from Buy. The latest guidance reduction was the second time in the last six months that the ...

On an action-packed day of trading, Moderna behaved like a meme stock. Here is what happened on December 20, and what investors should expect next.

Moderna (NASDAQ:MRNA) stock is on the move this week after the Centers for Disease Control and Prevention (CDC) updated Covid-19 booster shot recommendations. The CDC is now recommending that ...

On November 30th, exactly 3 years ago, Moderna’s (MRNA) stock was priced at $352.43, but after losing 87.69% of its value, MRNA stock is priced at $43.50. This downturn trajectory tells much of ...

Moderna's Q1 2022 financial performance was better than expected, but MRNA didn't raise full-year 2022 guidance. See if MRNA stock is a buy, sell, or hold.